S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
NASDAQ:HQY

HealthEquity - HQY Stock Forecast, Price & News

$62.52
-2.13 (-3.29%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$62.13
$64.87
50-Day Range
$57.65
$78.50
52-Week Range
$38.53
$79.20
Volume
817,756 shs
Average Volume
776,823 shs
Market Capitalization
$5.28 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$78.14

HealthEquity MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.82 Rating Score
Upside/​Downside
25.0% Upside
$78.14 Price Target
Short Interest
Healthy
3.79% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.34mentions of HealthEquity in the last 14 days
Based on 23 Articles This Week
Insider Trading
Selling Shares
$3.36 M Sold Last Quarter
Proj. Earnings Growth
63.77%
From $0.69 to $1.13 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.72 out of 5 stars

Medical Sector

59th out of 1,034 stocks

Business Services, Not Elsewhere Classified Industry

18th out of 94 stocks

HQY stock logo

About HealthEquity (NASDAQ:HQY) Stock

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.

Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

HQY Stock News Headlines

The Critical Minerals Race: U.S. v China
The U.S. is dangerously lacking in critical minerals such as cobalt, lithium, and rare earths needed to maintain our national security. China is aggressively locking up mines and production. But the U.S. is about to strike back with a forceful plan of action to increase domestic production.
HealthEquity (NASDAQ:HQY) PT Lowered to $101.00
HealthEquity (NASDAQ:HQY) PT Raised to $75.00
The Critical Minerals Race: U.S. v China
The U.S. is dangerously lacking in critical minerals such as cobalt, lithium, and rare earths needed to maintain our national security. China is aggressively locking up mines and production. But the U.S. is about to strike back with a forceful plan of action to increase domestic production.
HealthEquity (HQY) Set to Announce Quarterly Earnings on Tuesday
Analyst Ratings for HealthEquity
See More Headlines
Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

HQY Company Calendar

Last Earnings
12/06/2021
Today
12/09/2022
Fiscal Year End
1/31/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HQY
Employees
3,695
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$78.14
High Stock Price Forecast
$101.00
Low Stock Price Forecast
$56.00
Forecasted Upside/Downside
+25.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.82
Research Coverage
11 Analysts

Profitability

Net Income
$-44,290,000.00
Pretax Margin
-9.85%

Debt

Sales & Book Value

Annual Sales
$756.56 million
Cash Flow
$2.37 per share
Book Value
$22.28 per share

Miscellaneous

Free Float
82,164,000
Market Cap
$5.28 billion
Optionable
Optionable
Beta
0.81

Key Executives

  • Mr. Jon  KesslerMr. Jon Kessler (Age 54)
    Pres, CEO & Director
    Comp: $1.24M
  • Mr. Tyson Murdock (Age 51)
    Exec. VP & CFO
    Comp: $557.55k
  • Mr. Darcy G. MottMr. Darcy G. Mott (Age 69)
    Special Advisor
    Comp: $369.01k
  • Mr. Larry L. TrittschuhMr. Larry L. Trittschuh (Age 50)
    Exec. VP & Chief Security Officer
    Comp: $618.06k
  • Mr. Elimelech Rosner (Age 65)
    Exec. VP & CTO
  • Mr. Richard Putnam
    VP of Investor Relations
  • Mr. Delano  LaddMr. Delano Ladd (Age 41)
    Exec. VP, Gen. Counsel & Sec.
  • Mr. Steve Lindsay
    Exec. VP of Sales & Relationship Management
  • Mr. Brad Bennion
    Sr. VP of Corp. Devel.
  • Ms. Tia Padia
    Sr. VP of Marketing













HQY Stock - Frequently Asked Questions

Should I buy or sell HealthEquity stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 2 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HQY shares.
View HQY analyst ratings
or view top-rated stocks.

What is HealthEquity's stock price forecast for 2023?

11 Wall Street analysts have issued 12-month price objectives for HealthEquity's stock. Their HQY share price forecasts range from $56.00 to $101.00. On average, they predict the company's share price to reach $78.14 in the next year. This suggests a possible upside of 25.0% from the stock's current price.
View analysts price targets for HQY
or view top-rated stocks among Wall Street analysts.

How have HQY shares performed in 2022?

HealthEquity's stock was trading at $44.24 at the beginning of 2022. Since then, HQY stock has increased by 41.3% and is now trading at $62.52.
View the best growth stocks for 2022 here
.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) issued its quarterly earnings results on Monday, December, 6th. The company reported $0.35 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.35. The business earned $180 million during the quarter, compared to analyst estimates of $185.44 million. HealthEquity had a negative net margin of 7.07% and a positive trailing twelve-month return on equity of 2.82%. The business's quarterly revenue was up .3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.30 EPS.

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity issued an update on its FY23 earnings guidance on Tuesday, December, 6th. The company provided earnings per share (EPS) guidance of $1.26-1.35 for the period, compared to the consensus EPS estimate of $1.27. The company issued revenue guidance of $850-860 million, compared to the consensus revenue estimate of $839.51 million.

What is Jon Kessler's approval rating as HealthEquity's CEO?

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

What is HealthEquity's stock symbol?

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

Who are HealthEquity's major shareholders?

HealthEquity's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (11.46%), Vanguard Group Inc. (9.67%), State Street Corp (3.16%), Brown Advisory Inc. (2.44%), Mackenzie Financial Corp (2.24%) and Fred Alger Management LLC (2.10%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker and William Robert Otten.
View institutional ownership trends
.

How do I buy shares of HealthEquity?

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HealthEquity's stock price today?

One share of HQY stock can currently be purchased for approximately $62.52.

How much money does HealthEquity make?

HealthEquity (NASDAQ:HQY) has a market capitalization of $5.28 billion and generates $756.56 million in revenue each year. The company earns $-44,290,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis.

How many employees does HealthEquity have?

The company employs 3,695 workers across the globe.

How can I contact HealthEquity?

HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The official website for the company is www.healthequity.com. The company can be reached via phone at (801) 727-1000, via email at rputnam@healthequity.com, or via fax at 801-727-1005.

This page (NASDAQ:HQY) was last updated on 12/9/2022 by MarketBeat.com Staff